Loss Per Share

12 Months Ended

Dec. 31, 2022

Note 12. Loss Per Share

Basic loss per share is computed by dividing the net loss after tax attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is computed by including potentially dilutive securities outstanding during the period in the calculation of weighted average shares outstanding. The Company did not have any dilutive securities during the periods presented; therefore, diluted loss per share is equal to basic loss per share.

Presented in the table below is a reconciliation of the numerator and denominator for the basic and diluted loss per share calculations for the years ended December 31, 2022 and 2021:

	2022			2021
	December 31,
	2022			2021
Net loss from continuing operations	$	(15,807	)	$	(18,575	)
Net loss from discontinuing operations		(6,883	)		(22,284	)
Net loss	$	(22,690	)	$	(40,859	)
Basic and diluted weighted average shares outstanding		5,868,402			4,522,889
Basic and diluted net loss per share:
Continuing operations	$	(2.69	)	$	(4.11	)
Discontinuing operations		(1.18	)		(4.92	)
Net loss	$	(3.87	)	$	(9.03	)

The following securities were not included in the computation of diluted shares outstanding for the years ended December 31, 2022 and 2021 because the effect would be anti-dilutive:


	December 31,
	2022		2021
Common Stock warrants		455,139		459,382
Common Stock options		428,301		464,019
Restricted stock		77,104		-
Total		960,544		923,401
Anti-dilutive securities		960,544		923,401

Vyant Bio, Inc. 10-K